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ABSTRACT
DNA viruses are often used as vectors for foreign
gene expression, but large DNA region from cloned
or authentic viral genomes must usually be handled
to generate viral vectors. Here, we present a unique
system for generating adenoviral vectors by directly
substituting a gene of interest in a small transfec-
ted plasmid with a replaced gene in a replicating
viral genome in Cre-expressing 293 cells using the
recombinase-mediated cassette exchange (RMCE)
reaction. In combination with a positive selection of
the viral cis-acting packaging signal connected with
the gene of interest, the purpose vector was enriched
to 97.5 and 99.8% after three and four cycles of
infection, respectively. Our results also showed that
the mutant loxP V (previously called loxP 2272), a
variant target of Cre used in the RMCE reaction,
was useful as a non-compatible mutant to wild-type
loxP. This method could be useful for generating not
only a large number of adenovirus vectors simultan-
eously, but also other DNA virus vectors including
helper-dependent adenovirus vector.
INTRODUCTION
DNA viral vectors derived from adenoviruses, herpes viruses,
vaccinia viruses, baculoviruses and so on have contributed to
advances in both basic research and gene therapy. These vec-
tors are particularly useful owing to their high expression level
and the excellent stability of their viral genomes. However, the
construction of these vectors, i.e. the introduction of a gene of
interesttoaspeciﬁcsiteintheviralgenome,hasbeenhampered
by the large sizes of viral genomes ( 36–200 kb). Con-
sequently, viral vectors have been generated utilizing either
authentic viral genome DNAs from adenoviruses (1), vaccinia
viruses (2) or baculoviruses (3), or cloned full-length viral
DNAs of adenoviruses (4,5), Epstein–Barr viruses (6) or bacu-
loviruses(7).However,theselargesectionsofDNAaredifﬁcult
to handle, and the efﬁciency of obtaining viral vectors is low.
For ﬁrst-generation adenovirus vector construction, the
most efﬁcient method available to date is the COS–TPC
method (1), which utilizes viral genome DNA–terminal
protein complex (DNA–TPC) instead of a cloned intact
viral genome. This method is highly efﬁcient because DNA–
TPC yields  10
3-fold more infectious viruses than deprotein-
ated viral genomes (8) or cloned intact viral DNA. DNA–TPC
is usually prepared from puriﬁed virus particles but is, of
course, present abundantly in infected host cells as part of
the replicating viral genome. If a gene of interest could be
transferred directly into the replicating viral DNA–TPC in
these cells, vectors could be efﬁciently constructed without
manipulating large sections of viral genome DNA. Therefore,
we designed a novel approach where a gene of interest initially
located in a small plasmid is transferred directly to a speciﬁc
site in the replicating ‘recipient’ viral genome via a pathway
mediated by recombinase-mediated cassette exchange
(RMCE) and Cre recombinase.
The site-speciﬁc recombinase Cre, derived from bacterio-
phage P1, catalyzes the precise excision of DNA ﬂanked by a
pair of target sequences, loxP, in the same orientation. Cre also
exhibits another recombination activity: double-reciprocal
recombination or RMCE [(9) and for a review see (10)], in
which two DNA regions on different molecules are both
ﬂanked by a wild type (wt) and a mutant loxP sequence.
Cre exchanges the two regions ﬂanked by the wt and mutant
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doi:10.1093/nar/gni074loxP sequences while maintaining the orientation of the
regions. The mutant loxP 511 (11), which has a single-base
substitution within the central eight-base region of loxP, has
been used in the RMCE reactions (9,12–16). Ideally, such
‘exclusive’ mutants would not be able to recombine with
wt loxP, but would exclusively and efﬁciently recombine
only with identical mutant loxPs. We found a mutant loxP V
(previously called loxP 2272) with two-base substitutions
whose recombination efﬁciency was as high as that of loxP
511, but recombination with wt loxP was strictly undetectable
in an in vitro assay (17), an Escherichia coli system using the
M13phagemid(18),orinmammalianchromosomes(19).And
loxP V, together with wt loxP, has been successfully applied in
the RMCE reactions, yielding a higher ﬁdelity and efﬁciency
than those obtained by loxP 511 together with wt loxP using
embryonic stem (ES)cells with the selectionof drugresistance
(20,21). In the present study, we established a highly efﬁcient
method to produce adenoviral vectors by using the RMCE
reaction mediated by the Cre and the mutant loxP V without
the isolation of the viral clones. The method probably provides
an efﬁcient and a reliable tool not only for generating a large
number of adenovirus vectors at once, but also for other viral
vector construction and offers various applications in genetic
manipulation of mammalian cell chromosomes.
MATERIALS AND METHODS
Cell lines
The human embryonic kidney cell line, 293 (22), and the
monkey kidney cell line, CV1, were cultured in DMEM sup-
plemented with 10% fetal calf serum (FCS). The 293 cells
constitutively express adenoviral E1 genes and support the
replication of E1-substituted recombinant adenoviruses.
After infection with the recombinant adenoviruses, the cells
were maintained in DMEM supplemented with 5% FCS. The
293 cell line that constitutively expressed nuclear localization
signal (NLS)-tagged Cre recombinase under the control of the
CAG promoter (23) (termed 293FNCre) was isolated and
maintained with 10% FCS in DMEM containing 1.5 mg/ml
of geneticin. The characterization of this cell line will be
presented elsewhere.
Construction of recipient viruses
The mutant loxP V (V) used in this study was identical to
loxP 2272 (17,19), with two transversion mutations within
the eight-base central region (ATGTATGC) of wt loxP (L):
T to A at the second base and G to C at the seventh base. To
construct an expression unit ﬂanked by L and V, we ﬁrst
cloned the ‘L sequence-SwaI site-V sequence’ at the SacI
site of pUC19 (termed pUVwL). To construct the recipient
viruses using the COS–TPC method (1), the left-end fragment
of the adenovirus genome, including an L sequence at the end
of the viral-packaging signal, was introduced into the cassette
cosmid pAxcw (1) and termed pAx19Lcw (since the position
where the L sequence was introduced was at the SgrAI site,
191 bp from the left end of the adenovirus genome, we
included 19L in the name of the constructs). The ‘V-SwaI-
L’ unit from pUVwL was then cloned at the SwaI site of
pAx19Lcw; the resulting cassette cosmid for the recipient
virus was named pAxVwL19L. The expression unit of the
recipient viruses, which expresses LacZ or FLP recombinase
under the control of a human polypeptide elongation factor 1a
(EF-1a) promoter (24), was cloned at the SwaI site of
pAxVwL19L. Each cosmid was mixed with adenovirus
DNA–terminal protein complex and transfected to the
293 cells, resulting in the generation of recipient viruses
(Figure 2A) expressing LacZ (AxVEFZL19L) or FLP
(AxVEFFLPL19L) through homologous recombination.
Construction of the donor plasmid
The XhoI–SwaI fragment of pAxVwL19L containing the L
sequence and the viral-packaging signal was inserted into
pUVwL; the resulting cassette donor plasmid for the gene of
interest was named pUVw19L. The expression unit of the GFP
gene in the donor plasmid was derived from pxCAEGFP (25)
[originallyderivedfrompEGFP-C1(EGFPvector;Clontech)],
and cloned at the SwaI site of pUVw19L (termed pUV-
CAGFP19L or D; Figure 2A, left). Another plasmid lacking V
(termed pUCAGFP19LDVo rDV; Figure 2A, right) was also
constructed to serve as a negative control.
Production of first-generation adenovirus
vector by RMCE
Under standard conditions, 293FNCre cells were infected with
the recipient virus at an MOI of 1 and cultured in a 6-well plate
for 1 h, followed immediately by the transfection of the donor
plasmid at 3.0 mg/well using TransFast (Promega). When a
viral cytopathic effect was clearly observed (normally 5 days
after infection, under the above conditions), the cells were
harvested together with the medium ( 1.5 ml/well). The cell
suspension was then sonicated for 3 min (6 cycles, 30 s each)
using a Bioruptor II sonicator (CosmoBio, Tokyo, Japan) at
maximumpower(200W)andcentrifugedat1900g(5000r.p.m.;
Tomy TMP 11 rotor) for 5 min at 4 C using a microcentrifuge.
Thesupernatant wasstoredat 80 Casavirusstock(‘passage
1 stock’). To enrich the purpose vector by eliminating the
residual recipient virus, 293FNCre cells were infected with
50 ml of the virus stock and cultured in a 6-well plate. A total
of ﬁve passages were performed (including the initial infec-
tion step), and each virus stock was prepared as described
above. The production of the purpose vector was monitored
by green ﬂuorescent protein (GFP) expression observed using
a ﬂuorescence microscope (IX70; Olympus) throughout the
culture period.
Titration of the produced purpose vector
The total virus titer (PFU/ml) and the purpose vector titer
[GFP-expressing units (GEU)/ml] of the passage 1 stock
were measured using an end-point assay, as described previ-
ously (26). Brieﬂy, 50 ml of DMEM with 5% FCS was dis-
pensed into each well of a 96-well plate and 8 rows of 3-fold
serial dilutions of the initial virus stock, starting at a dilution of
1:10 were prepared, followed by the addition of 293 cells
(3 · 10
5 cells) in 50 ml of the medium to each well. Twelve
days later, the end point of the cytopathic effect of the total
viruses or GFP-expressing viruses was determined by using
microscopy, and the 50% tissue culture infectious dose
(TCID50) was calculated. In our laboratory, 1 TCID50/ml
corresponded to  1 PFU/ml (26).
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To detect the ‘infectious virus’ DNA of purpose vector and the
residual recipient viruses, CV1 cells were infected with the
virus stocks at 100 ml per 6 cm dish. After 24 h, the total DNA
was prepared from the dish according to the method described
by Saito et al. (27). After AﬂII digestion, 20 mg of the DNA
was electrophoresed on a 0.8% agarose gel at 35 V for 17 h.
Before alkaline treatment, the gel was exposed to 0.1 N HCl
for partial depurination (28), and the DNA was then trans-
ferred onto a Hybond-N nylon membrane (Amersham Bio-
sciences) using the capillary-transfer method (29). Speciﬁc
DNA was detected with a DIG DNA Labeling and Detection
kit (Roche Diagnostics). A 0.3 kb XhoI–BspEI fragment of the
C gene, a 3.4 kb KpnI–XmnI fragment of the C-GFP gene and
a 0.3 kb AﬂII–BstEII fragment of the adenovirus genome
(corresponding to the coding region of the viral protease gene)
were labeled with digoxigenin-UTP as probes (Figure 2A),
and speciﬁc DNAs were detected by autoradiography using
chemiluminescence of CDP-Star (Roche Diagnostics).
Ratio of purpose vector to recipient viruses
To determine the ratio of produced purpose vector to residual
recipient viruses, the total DNA was extracted from CV1 cells
infected with each virus stock and was subjected to Southern
blotting or quantitative real-time PCR. Since the ‘carryover’
donor plasmid DNA was transferred to the CV1 cells when the
passage 1 stock was used (Figure 2C), the results of the real-
time PCR were disturbed by this DNA. Hence, for passages
1 and 2 stocks, we quantiﬁed the density of the speciﬁc bands
using Southern blot analysis, while for passage 3–5 stocks we
measured the amount of each viral DNA using real-time PCR.
TaqMan primers and probes speciﬁc for the GFP gene in the
purpose vector (forward primer, 50-CTG CTG CCC GAC
AAC CA-30; reverse primer, 50-TGT GAT CGC GCT TCT
CGT T-30; and TaqMan probe, 50-FAM-CTG AGC ACC CAG
TCC GCC CTG-TAMRA-30) and speciﬁc for the LacZ gene in
the recipient virus (forward primer, 50-GGC TTT CGC TAC
CTG GAG AGA-30; reverse primer, 50-GTA TTT AGC GAA
ACC GCC AAG AC-30; and TaqMan probe, 50-FAM-TGA
TCC TTT GCG AAT ACG CCC ACG-TAMRA-30) were
designed using Primer Express software. The difference in
the detection efﬁciency between the GFP and LacZ genes
was corrected using the control plasmid pEFVGV-CALNLZ
(19),containing bothGFP and LacZ gene on the sameplasmid.
RESULTS
Production of adenovirus vectors using RMCE
Usingournovelmethod, a‘gene ofinterest’inadonorplasmid
was substituted for a ‘replaced gene’ initially located in a
replicating recipient virus genome using RMCE, together
with apositiveselection toeliminate residualrecipient viruses,
via viral cis-element excision (Figure 1). The ‘recipient virus’
genome contained a viral cis-element (denoted by *) ﬂanked
by a pair of wt loxP sequences (denoted by L) and a replaced
gene ﬂanked bywtloxP andthemutant loxP V(denotedbyV),
while a ‘donor plasmid’ contained a linked set of viral cis
element and a gene of interest ﬂanked by L and V. When the
recipient virus and the donor plasmid were co-introduced into
a Cre-expressing cell line, the purpose vector was produced as
a result of the Cre-mediated excision of the viral cis-element in
the recipient virus and the subsequent RMCE of the replaced
gene in the Dcis-element recipient virus with the gene of
Figure 1. Strategy for the generation of viral vectors using the RMCE reaction. L, wt loxP and V, mutant loxP V.
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attempted to use this method to produce a ﬁrst-generation
adenovirus vector as a model.
To produce a ﬁrst-generation adenovirus vector using
RMCE, we ﬁrst established a 293 cell line, 293FNCre, that
constitutively expressed an NLS-tagged Cre (NCre). When
the 293FNCre cells were infected with viruses bearing a
pair of wt loxP sequences, AxCALNLZ (25), AxVEFZL19L
and AxVEFFLPL19L described below,  80% of the
replicating viral genome underwent Cre-mediated excision
(data not shown). A similar level of Cre expression was repor-
ted by Parks et al. (30) We then prepared two different recipi-
ent viruses expressing LacZ and FLP (denoted as the LacZ
recipient and the FLP recipient or AxVEFZL19L and
AxVEFFLPL19L, respectively, in Figure 2A) and compared
the efﬁciency of the production of a purpose vector containing
the donor plasmid-derived GFP gene. Note that the function of
the FLP gene per se was not signiﬁcant. In these recipient
A
∆ ∆
∆
∆
Figure 2. Production of a first-generation adenovirus vector by Cre-mediated RMCE. (A) Structure of the donor plasmids, recipient viruses and purpose vector.
pUVCAGFP19L (top left), donor plasmid carrying a GFP-expression unit flanked by L and V. pUCAGFP19LDV (top right), control plasmid lacking V.
AxVEFZL19L and AxVEFFLPL19L, LacZ and FLP recipient viruses, respectively. AxVCAGFP19L, purpose vector. The position of the probes (closed bars,
bottom) and the size (kb) of the specific bands corresponding to fragments from the recipient viruses (Z4.7 or F3.0), the purpose vector (P3.5) and the adenovirus
constant region (2.3) detected by Southern blotting are shown. V, a mutant loxP V; CAG, CAG promoter; GFP, green fluorescent protein; GpA, rabbit b-globin
poly(A) signal; C, viral-packaging signal; L, wild-type loxP;A p
r, ampicillin-resistance gene; ori, plasmid replication origin; EF-1a, EF-1a promoter; SpA, SV40
earlypoly(A)signal;andA,AflIIsite.(B)Virustiteroftheproducedpurposevectorandresidualrecipientvirusesinpassage1stock.TheindicatedMOIsarethosefor
the initial infection of the 293FNCre cells with the recipient viruses. PFU, plaque-forming units; GEU, GFP-expressing units. (C) Detection of the infectious viral
genomesinpassage1stock.293FNCrecellswereinfectedwithLacZ(lanes1–3)orFLP(lanes4–6)recipientvirusesatanMOIof2or1andculturedina6-wellplate,
followedbytransfectionwiththedonorplasmid(D)orthecontrolplasmid(DV)at3.0mg/well.Thepassage1stockwaspreparedonday5andthenusedtoinfectCV1
cellstodetecttheinfectiousviralgenomes.Specificbandscorrespondingtofragmentsfromthepurposevector(P3.5)andeachrecipientvirus(LacZ,Z4.7;FLP,F3.0)
weredetectedusingSouthernblottingwithC(upperpanel)orC-GFPprobes(lowerpanel)usingthesamenylonmembrane.ThebandsrepresentingD6.6andDVcir,
correspondingtoAflII-cleaved6.6kbpUVCAGFP19LdonorandcircularpUCAGFP19LDV,respectively,appeartobe‘carryover’DNAinitiallytransfectedtothe
293FNCre cells and then co-transferredto the CV1 cells, together with the adenoviral infection(36). These bands were not detected at and after the second cycle of
infection(datanotshown).NotethattheDNAwasdetectedasanAflII-digestedlinearformofthedonorplasmidandacircularformofthecontrolplasmid.Thebands
indicatedbytheasterisk(*)appeartohavebeencausedbyrecipientvirusescarryingtwopackagingsignalsgeneratedbythere-integrationoftheexcisedcircularC
into either loxP site on the recipient viral genomes.
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viral cis element (*) shown in Figure 1, while the LacZ-
and FLP-expression units corresponded to the replaced
gene. The 293FNCrecells were infected with one ofthe recipi-
ent viruses at a multiplicity of infection (MOI: PFU/cell) of 1
or 2, followed by the transfection of the donor plasmid (Figure
2A) at 3.0 mg/well on a 6-well plate. Under these conditions, a
viral cytopathic effect was observed on day 5. The cells were
harvested, and the virus stock (referred to as ‘passage 1 stock’)
was prepared. The initial viral titer of the purpose vector
produced by the RMCE was determined by infecting authentic
293 cells on 96-well plates with serially diluted passage 1
stock. The total virus titer, i.e. the residual recipient virus
plus the purpose vector (PFU/ml), and the titer of the purpose
vector only (GEU/ml) were then determined by observing the
end point of the viral cytopathic effect and GFP-expressing
ﬂuorescent cells, respectively (Figure 2B). A signiﬁcant titer
(1 · 10
5to 2· 10
6GEU/ml)of GFP-expressing purpose vector
was detected in the passage 1 stock, showing that the purpose
vector was efﬁciently generated by the RMCE. Moreover,
the titer of purpose vector expressing GFP (closed bar) was
higher when each recipient virus was infected at an MOI of 1,
rather than at an MOI of 2. The titer was also higher when
the LacZ recipient, rather than the FLP recipient was used;
when both recipients were infected at an MOI of 1, the
percentages of purpose vector in the initial viral stock were
 30 and 4%, respectively, based on the GEU/PFU ratio
(Figure 2B).
To conﬁrm the efﬁcient production of the purpose vector,
the viral genomes of the infectious particles in the passage 1
stock were analyzed as follows. CV1 cells were infected with
the passage 1 stock and then, 24 h later, completely washed
with PBS ( ) to remove any viral particles remaining on the
surfaces of the cells. The total DNA, including the infectious
viral genomes of the produced purpose vector and the residual
recipient virus, was then extracted, digested using AﬂII, and
subjected to Southern blotting using a C or C-GFP probe
(Figure 2C, upper and lower panels, respectively; the positions
of the probes are shown in Figure 2A, bottom). The C probe
detected the left-end fragments (denoted Z4.7, F3.0 and P3.5)
of the two residual recipient viruses, the purpose vector and
‘carryover’ donor plasmid DNA (see Figure 2C legend) with
uniform sensitivity, while the C-GFP probe was designed to
detect the purpose vector-derived P3.5 fragment  10-fold
more strongly than the other fragments. When the cells were
infected with one of the recipient viruses at an MOI of 1
(Figure 2C: LacZ, lane 2; FLP, lane 5), the P3.5 bands within
the total DNA from the CV1 cells were faintly detected by
the C probe (upper panel), but were clearly detected by the
C-GFP probe (lower panel). When an MOI of 2 was used
(LacZ, lane 1; FLP, lane 4), the P3.5 bands were only detected
by the C-GFP probe (lower panel). In contrast, the P3.5 bands
were not detected when a control plasmid lacking V (denoted
DV) was transfected instead of the donor plasmid (D) (lanes 3
and 6, both panels).These results showed that a purpose vector
with the expected structure was indeed produced by the
RMCE. The percentage of purpose vector to the residual
recipient viruses expressing LacZ (P3.5 to Z4.7) or FLP
(P3.5 to F3.0) was higher when the lower MOI was used
(lane 1 versus lane 2 for LacZ and lane 4 versus lane 5
for FLP) and when the LacZ recipient, rather than the FLP
recipient was used (lane 2 versus lane 5), conﬁrming the result
of the viral titration described above.
Optimization of vector production
To optimize the conditions for efﬁcient production of the
purpose vector, 293FNCre cells were infected with the LacZ
recipient at an MOI of 2 or 1, transfected with various amounts
of the donor plasmid, and the passage 1 stock was prepared.
The viral genomes of the produced purpose vector and the
residual recipient virus in infectious particles within the stock
were then analyzed using the C-GFP probe (Figure 3A) as
described above. The ratio of the purpose vector to the residual
recipient virus (Figure 3A, P3.5 to Z4.7) was clearly higher
whenthe donor plasmid was transfected at 3.0 mg/well (lanes 3
and 4) than when it was transfected at 1.5 mg/well (lanes 1 and
2), irrespective of the MOI. No notable improvement was
obtained when the amount of the donor plasmid was increased
to 6.0 mg/well (lanes 5and 6). Thus, we ﬁxed the amount ofthe
donor plasmid at 3.0 mg/well in subsequent experiments. We
then optimized the MOI by infecting 293FNCre cells with the
LacZ recipient at various MOIs (Figure 3B), followed by
donor plasmid transfection. The purpose vector was produced
more efﬁciently when an MOI of 1 or 0.5 (lanes 3 or 4) was
used, compared with when an MOI of 4 or 2 (lanes 1 or 2) was
used; thus, an MOI of  1 or 0.5 was selected as optimal,
although the percentage of the purpose vector increased fur-
ther when a lower MOI was used (see below). The percentage
of purpose vector in the passage 1 stock was quantiﬁed as
 25% when the LacZ recipient, an MOI of 0.5, and a donor
plasmid amount of 3.0 mg/well of the donor plasmid were
used. (Figure 3B, lane 4 and Table 1, ﬁrst row, right. Note
that the C-GFP probe was used in Figure 3B.)
A
B
Figure3.OptimalconditionsforproducingadenovirusvectorbyCre-mediated
RMCE.Thevirusstockwaspreparedonday5andthenusedtoinfectCV1cells
for a Southern blot analysis. Note that the C-GFP probe was used to detect
the specific bands. The results were reproduced in three experiments, and a
representative result is shown. (A) Optimal amount of the donor plasmid
DNA. 293FNCre cells were infected with the LacZ-expressing recipient virus
atanMOIof2or1andculturedina6-wellplate,followedbytransfectionwith
the indicated amounts of donor plasmid (mg/well). (B) Optimal MOI of the
recipient virus. 293FNCre cells were infected with the LacZ-recipient virus
at the indicated MOIs, followed by transfection with the donor plasmid at
3.0 mg/well.
PAGE 5 OF 8 Nucleic Acids Research, 2005, Vol. 33, No. 8 e76Vector purification by serial passage
Since the produced purpose vector can replicate by itself and
theresidualrecipientvirusesareeventuallyeliminatedbecause
oftheexcisionofaviral-packagingsignal(C),thevectorstock
can be puriﬁed by serial passages in Cre-expressing 293 cells
or isolated by limiting dilutions in authentic 293 cells. To
purify the purpose vector, 293FNCre cells were infected
with 50 ml of the passage 1 stock and cultured in a 6-well
plate; passage 2 stock was then prepared on day 5. A total of
ﬁve passages were performed (including the initial infection
step), and each prepared viral stock was used to infect CV1
cells for a Southern blot analysis of the infected viral genomes
from infectious particles (Figure 4). The ratio of purpose
vector to residual recipient virus (P3.5 to Z4.7) dramatically
increased with each passage in the 293FNCre cells, especially
when an MOI of 0.5 was initially used (right panel), and the
Z4.7 band speciﬁc for the recipient virus was no longer detect-
able after the fourth passage at an MOI of 2 (lane 4) or after the
third passage at an MOI of 0.5 (lane 8). When initiated at an
MOI of 0.5, the percentage of purpose vector in the stock
reached  80–90% after no more than two passages (Table 1),
indicating that only 10 days are required to produce an aden-
ovirus vector sufﬁcient for practical screening applications.
Moreover, a stock purity of 99.8% was obtained after four
passages.
DISCUSSION
In the present study, a novel system for producing viral vectors
was established based on an RMCE reaction mediated by Cre
recombinase and the mutant loxP V. Here, we demonstrated
the efﬁcient production of a ﬁrst-generation adenovirus vector
by the replacement of a speciﬁc gene (replaced gene) in the
replicating adenovirus genome with a gene of interest from
plasmid DNA in Cre-expressing 293 cells (293FNCre cells).
Although the ﬁrst successful example of the RMCE was repor-
ted using FLP/FRT system (31), we chose Cre/loxP system
because Cre is much more active,  90-fold more, than FLP in
the recombination efﬁciency in mammalian cells (32).
Several factors were found to be important for the efﬁcient
construction of adenovirus vectors using the RMCE reaction.
First, two different recipient viruses, a LacZ recipient and an
FLP recipient, were used and the former recipient was found to
produce the purpose vector much more efﬁciently than the
latter, based on the viral titers (Figure 2B) and a Southern
blot analysis of the infectious viral genomes (Figure 2C).
The structures of both recipient viruses were identical, except
for the inserted genes (LacZ and FLP). A possible reason for
the difference in vector production efﬁciencies may be due to
the differences in the genome sizes of the recipient viruses.
Relativetothesizeofthewtadenovirus-5 genome(35935nt=
100%), the genome of the LacZ recipient was much larger
(103.5%) than those of the FLP recipient (97.8%) and the
GFP-expressing purpose vector (95.4%). In general, when
two viral clones with different genome sizes are simultan-
eously replicated in the permissive cells, the virus with the
shorter genome tends to become dominant, probably because
shorter genomes replicate faster than longer ones (Y. Kanegae
and I. Saito, unpublished data). A recipient virus with a gen-
ome larger than that of the LacZ recipient described here may
be difﬁcult to construct, since such a genome size would be
near the upper limit of the adenovirus packaging (105%) (33).
Therefore, the purpose vector has two different selective
advantages against the LacZ recipient virus; the majority of
the recipients were not packaged by excision of their pack-
aging signal, and the purpose vector outgrew the recipients of
much larger size.
On the other hand, if undesired recombination between wt
loxP (L) and loxP V (V) should occur, viruses lacking either a
replaced gene or a gene of interestwouldbe generated (refer to
Figure 2A), and such viruses would replicate much faster and
might become majority of the viral population. Langer et al.
(34) faced this problem in construction of adenoviral vector
when using loxP 511 by RMCE and hence their trial was
unsuccessful. Although the loxP 511 was the ﬁrst mutant
applied to the RMCE reaction as an ‘exclusive’ or ‘non-com-
patible’ mutant loxP, our in vitro analyses revealed that most
of the mutant loxPs with single-base substitutions, including
loxP 511, slightly but reproducibly recombined with wt loxP
(17). In contrast, most of the mutant loxPs with two-base
substitutions exhibited a high ﬁdelity against wt loxP but a
low recombination efﬁciency with identical mutant loxP,
while the mutant loxP V showed both a high ﬁdelity and high
recombination efﬁciency not only in vitro analysis, but also in
mammalian cells. In the present study, the viruses without an
insert were not evident and did not disturb the process of the
vector construction, even though thousands of copies of viral
Table 1. Ratio of produced purpose vector to residual recipient viruses during
passages through 293FNCre cells
Passage Ratio (purpose vector:recipient virus)
MOI 2
a MOI 0.5
a
1
b 5:95 25:75
2
b 40:60 85:15
3
c 93.0:7.0 97.5:2.5
4
c 98.5:1.5 99.8:0.2
5
c 99.9:0.1 99.97:0.03
aThe initial MOIs used to infect the 293FNCre cells with the LacZ-recipient
virus are shown.
bThe estimated percentages by quantifying the density of the Z4.7- and
P3.5-bands specific to the purpose vector and the recipient virus, respectively.
cThe estimated percentages by measuring the amounts of the infectious viral
genomeofthepurposevectorandtherecipientvirususingquantitativereal-time
PCR by detecting GFP and LacZ genes, respectively.
Figure 4. Purification of the purpose vector by serial passage. CV1 cells
infected with passages 1–5 stocks were used in a Southern blot analysis.
The initial MOIs (MOI 2, left panel; 0.5, right panel) used to infect the
293FNCre cells with the LacZ-recipient virus are shown. The C probe and
Ad probe were simultaneously used to detect specific bands. The results were
reproduced in three experiments, and a representative result is shown.
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ﬁfth serial passage using the LacZ recipient, no putative virus
genome lacking an insert was detected, showing such virus, if
any, was present at most 20-fold less than the purpose vector
(M. Ishimura and Y. Kanegae, unpublished data). In addition,
the designs of the virus structures in the present study were
chosen such that the recipient virus and the purpose vector
would lose their viral packaging signal if L–V recombination
occurred (Figure 2A).
Second, our data showed that a low initial MOI (1.0 or 0.5)
of the recipient virus produced a much higher ratio of the
purpose vector (Figure 3B), suggesting that only a small
amount of recipient virus is required by using this method.
This result may indicate that large amounts of recipient virus
are difﬁcult to eliminate and that a small amount of recipient
virus is sufﬁcient to generate purpose vectors. However, we do
not recommend using an MOI of <0.5 because we observed
undesired generation of rearranged viruses containing only
part of the gene of interest, probably because uncontrolled
multiple cycles of infection occurred within a single passage
(data not shown).
Third, using the LacZ recipient, we observed that the pur-
pose vector was puriﬁed and the recipient virus was eliminated
during serial passages. The proportion of recipient virus in the
stock constantly decreased by  5–10-fold per passage, reach-
ing a percentage of no more than 0.03% after ﬁve cycles of
infection (Table 1). This result shows that the residual recipi-
ent virus can be efﬁciently eliminated from the stock, irre-
spective of the amount of residual recipient virus, by excising
the packaging signal. Suprisingly, the percentage of purpose
vector in the stock after the initial infection cycle reached as
high as 25% without any kind of external selection. One obvi-
ous reason for such high efﬁciency was that, in our construc-
tion design, the genome of the purpose virus grew faster than
that of the recipient viruses depending on the genome size,
evenwithintheinitialcycle.However,theefﬁciencyofRMCE
itself might be more important. Previous reports (20,21) using
RMCE method and loxP V were concerned about drug-
selected isolation of purpose cell clones in murine ES cell
lines and hence the efﬁciency of RMCE was not examined.
Our preliminary results, using CV1 cells, which is replication-
non-permissive for adenovirus vector, indicated that without
any selection, approximately no <1% of the infected cells did
receive the GEU throughthe RMCEreaction (datanot shown).
The method described here is the ﬁrst successful example of
RMCE applied to the construction of viral vectors in mam-
malian cells. For adenovirus vector construction, this method
provides several unique features, compared with the conven-
tional methods. First, this method only requires that a small
donor plasmid containing cDNA be introduced into the vector,
while other methods require very large plasmids or cosmids
containingnearlythefull-lengthofadenovirusgenome(1,4,5).
These large plasmids are often difﬁcult to handle, especially
for new users of adenovirus vectors. RMCE-related system
using att of lambda phage have been commercially available
recently (35). Because, however, lambda-phage recombina-
tion system can work only within E.coli, large viral genome
should be handled before the generation of viral vector.
Second, a purpose vector can be quickly obtained by trans-
fection plus infection followed by more than three times
serial passages. Although this virus stock contained a trace
of remaining recipient virus, the pure purpose virus can be
readily isolated using limiting-dilution, if desired.
Therefore, this simple and efﬁcient method will probably
be useful in genomic/proteomic approaches for expression
screening using adenovirus vectors not only in culture cell
but also in vivo directly when hundreds of cDNA candidates
are to be examined. Using this method, a set of 24- or even
96-different recombinant adenoviruses could be obtained by
transfecting 293FNCre cells with a large set of donor plasmids
in a multiple-well plate and subsequently infecting the cells
with the recipient virus for serial passages (using the same
multi-well plate layout). The purpose vector would become
dominant after about three cycles, without requiring the tedi-
ous isolation of each recombinant virus. After expression
screening, the desired adenoviral clones could be readily
isolated for further large-scale expression experiments or
for use in animal experiments.
The present work shows that a given DNA plasmid
sequence can be efﬁciently transferred into a DNA viral gen-
ome using a viral cis element, such as the packaging signal
utilized in the present study. Therefore, this method could be
used for the construction of large DNA vectors other than
ﬁrst-generation adenovirus vectors. The study of DNA viruses
with large genomes, such as various herpes viruses, including
Epstein–Barr virus, could probably have beneﬁts from this
technique. This method may also be applicable to the devel-
opmentofhelper-dependent adenovirus vectors (30) generated
by the substitution of  30 kb of foreign DNA. This possibility
is now being studied in our laboratory.
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